About Zinc finger protein 92 homolog
Zinc finger protein 92 homolog (ZFP92) is a protein
from Homo sapiens identified by UniProt accession
A6NM28, 416 residues long.
MolForge cross-references it against 0 known binders and
63 disease associations.
Target properties
| Protein name | Zinc finger protein 92 homolog |
| UniProt accession | A6NM28 |
| Gene | ZFP92 |
| Organism | Homo sapiens |
| Length | 416 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (63)
Diseases linked to this target (Open Targets).
- early-onset non-syndromic cataract · score 0.10
- hereditary hyperferritinemia with congenital cataracts · score 0.08
- isolated ectopia lentis · score 0.08
- Posterior polar cataract · score 0.08
- Total congenital cataract · score 0.07
- Cataract-microcornea syndrome · score 0.07
- cataract 38 · score 0.07
- cataract 13 with adult I phenotype · score 0.07
- Anterior polar cataract · score 0.07
- cataract · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-A6NM28-F1 | alphafold | PREDICTED | 71.50 | — |
Amino-acid sequence (416 residues)
MAAILLTTRP KVPVSFEDVS VYFTKTEWKL LDLRQKVLYK RVMLENYSHL VSLGFSFSKP HLISQLERGE GPWVADIPRT WATAGLHIGD RTQSKTSTST QKHSGRQLPG ADPQGGKEGQ AARSSVLQRG AQGLGQSSAA GPQGPKGAEK RYLCQQCGKA FSRSSNLIKH RIIHSGEKPY ACPECGKLFR RSFALLEHQR IHSGEKPYAC PECSKTFTRS SNLIKHQVIH SGERPFACGD CGKLFRRSFA LLEHARVHSG ERPYACPECG KAFSRSSNLI EHQRTHRGEK PYACGQCAKA FKGVSQLIHH QRSHSGERPF ACRECGKAFR GRSGLSQHRR VHSGEKPYEC SDCGKAFGRR ANLFKHQAVH GARRPAKAET ARRLAGPGST GPGSAVAATS PPRPSTAARP SRPSRR
Explore Zinc finger protein 92 homolog with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets